Affiliation:
1. Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL, USA
Abstract
Abstract
Omicron is currently the dominant variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus responsible for the coronavirus disease 2019 (COVID-19) pandemic. Omicron is associated with mild symptoms, although it can cause harmful effects in high-risk patient populations. Omicron and COVID-19 affect multiple organ systems, including the respiratory system, gastrointestinal tract, cardiovascular system, central nervous system, ophthalmic system, genitourinary tract, and musculoskeletal system. COVID-19 infects additional organ systems, including the hematological system, hepatobiliary system, renal system, and dermatologic system. The viral-induced complications were compared to discuss the effects of Omicron versus the authentic SARS-CoV-2 virus, revealing less detrimental outcomes for Omicron. Moreover, COVID-19 is more likely to infect older adults, males, and obesity with mild to severe symptoms. Omicron causes mild symptoms in younger populations and overweight females. Data were acquired using PubMed, Centers for Disease Prevention and Control, and the World Health Organization. COVID-19 and Omicron mechanisms causing organ system-related complications are likely because of the natural immune response to the active infection, the uncontrollable release of cytokines causing cytokine release syndrome, and direct viral damage through angiotensin-converting enzyme 2/transmembrane serine protease 2 receptor binding and entrance to the host cell for infection.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Emergency Medicine,Critical Care and Intensive Care Medicine
Reference41 articles.
1. Probable transmission of SARS-CoV-2 omicron variant in quarantine hotel, Hong Kong, China, November 2021;Emerg Infect Dis,2022
2. COVID-19 induced renal injury differs from that in other viral-infections;Emerg Crit Care Med,2022
3. Binding of human ACE2 and RBD of Omicron enhanced by unique interaction patterns among SARS-CoV-2 variants of concern;bioRxiv,2022
4. Omicron variant (B.1.1.529): infectivity, vaccine breakthrough, and antibody resistance;J Chem Inf Model,2022
5. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts;J Leukoc Biol,2020